Early stage of a human embryo. Photo: Harimiao/Wikimedia Commons
Researchers have successfully grown model versions of early human embryos by reprogramming cells from human skin. The breakthrough potentially opens up new ways to study the earliest phases of human development, learn more about developmental disorders, infertility and genetic diseases, and perhaps even improve the success of in vitro fertilisation (IVF) treatment.
In a study published in Nature today, a team led by our colleague Jose Polo discovered that when skin cells are treated in a particular way, 3D structures similar to early human embryos form. A US-Chinese research group led by Jun Wu also reported a similar feat, creating structures that resemble a very early stage of the embryo called a blastocyst.
While this is an exciting scientific advance, it will also be vital to consider the ethics behind this and other emerging approaches to modelling human development.
Organs in a dish
Over the past 50 years, research has revealed a lot about how the different organs of our bodies are formed, and what happens at a cellular level during disease and illness.
Many of these insights came from recent breakthroughs in stem cell research, in which scientists can effectively create 3D models, or miniature organs from human tissue, that resemble the structure and function of particular organs in the body.
These structures, known as organoids, have been used to understand how kidneys form, learn what happens to the developing brain during a Zika infection, and to test an array of therapies to find the best ways to halt the progression of bowel or pancreatic cancers.
These advances rely on the innate ability of stem cells to organise themselves into characteristic anatomical and functional features when given the right conditions. Researchers can use stem cells taken from a patients own tissue to create 3D models of the organ from which those cells were taken. Many, but not all, organs have their own specific stem cells.
Other approaches use a more basic type of stem cell, called pluripotent stem cells, obtained from human embryos or created in the lab from a skin or blood cell through a process called reprogramming. This approach means researchers can create stem cells then coax them to mimic how a particular organ forms. While these 3D structures are often referred to as mini-organs, they usually only replicate certain aspects of the organs architecture and function.
Black box of development
While stem cells can reveal much about how organs form, research so far has provided little insight into the complex interplay between the developing embryo and the lining of the womb required to establish and maintain a pregnancy.
This period, covering the first few weeks after implantation, is sometimes referred to as the black box of development, as it is extremely difficult to access reproductive material at this early stage.
Whats more, even in countries that allow research on donated IVF embryos, studies are usually limited to just the first 14 days after fertilisation, and alternative animal models are of little value in revealing the unique process of human embryo implantation.
With miscarriages affecting 1 in 6 pregnancies, and high rates of infertility due to failure of embryos to implant, we need better ways to understand and address these devastating outcomes.
Creating 3D models
Human pluripotent stem cells have been used to create structures that replicate specific aspects of development, but not the entire embryo, at and immediately after implantation.
The new discoveries reported today offer another way to explore development around the time of implantation. Unlike animal studies, in which the 3D model embryo is compiled by assembling cells from pre-established stem cell lines, this approach relied on adapting the technology used to create induced pluripotent stem cells.
In the approach taken by Polos group, skin cells from adult donors were first treated to reprogram them over several weeks, effectively resetting their development back to an earlier, less specialised state.
The researchers then grew these cells in 3D clusters for six days, after which some of them formed structures very similar to blastocysts the final stage of embryonic development before implantation. These lab-grown structures are dubbed iBlastoids.
The second group cultured human pluripotent stem cell lines both embryonic stem cell lines and those created through reprogramming in a slightly different two-step process to encourage 3D clusters to form. They called their structures blastoids.
While iBlastoids and blastoids both seem to be structurally and functionally similar to real blastocysts, it is not yet clear exactly how closely they resemble true embryos formed by a sperm and an egg. While the models were shown to share gene patterns and respond in culture in ways characteristic of actual embryos, researchers also saw significant anomalies, such as unsynchronised growth and cells that are not usually present in an embryo.
It can be hard to decide where we should draw the ethical line between using stem cells to grow model embryos, and research on real human embryos created by IVF.
Some people may see no ethical distinction between these two processes at all. Others might support the creation of models but only for specific types of research, such as to understand the origins of infertility or genetic disease. Those people may draw the line at attempts to use these models to test gene-editing techniques to correct genetic diseases rather than simply study them.
When considering these ethical issues, we need to address three important questions:
While 3D models are not human embryos, existing national laws around the creation and use of IVF embryos may provide useful guidance and oversight. Many countries have specialised review committees to provide independent advice to researchers and ensure ethical transparency.
Also read: Editing Embryos Six Steps to an Informed Opinion
Above all, we need to approach this issue carefully. The science is complex, and likely to trigger many of the same concerns raised 25 years ago by breakthroughs in cloning technology. One thing seems clear, just as it was back then: this new technology should only be used for laboratory research. Any attempt to use it to establish pregnancies in humans or animals must be strictly prohibited.
The International Society for Stem Cell Research will soon release a new set of guidelines that are likely to provide more explicit recommendations for research in human embryo modelling. As it has done in the past for other ethically charged issues, this global approach is essential. There is too much at stake to ignore the complexities.
Megan Munsieis deputy director of Centre for Stem Cell Systems and head of engagements, ethics and policy program for Stem Cells Australia at The University of Melbourne. Helen Abud is director of the organoid program at the Monash Biomedicine Discovery Institute.This article was first published onThe Conversation. Read the original article.
- Cellino Biotech developing tech to help scale stem cell therapies - MedCity News - April 14th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand -... - April 14th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 14th, 2021
- eQcell Inc Announces the Appointment of Members of the Board of Directors - BioSpace - April 14th, 2021
- Researchers Receive Grant to Improve Cellular Therapies to Treat 'Incurable' Diseases - University of Arkansas Newswire - April 14th, 2021
- Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform - Technology Networks - April 14th, 2021
- New consortium aims to accelerate development of stem cell-based therapies for Huntingtons disease - News-Medical.Net - April 10th, 2021
- Strengthening the Stem Cell Industry Through Better Regulation - The Regulatory Review - April 10th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Research, Patents, Funding Events, Industry Partnerships, Biomedical... - April 10th, 2021
- Stem Cell Transplantation May Be Offered Less Often as a Treatment Option for Some Patients with Mantle Cell Lymphoma - Curetoday.com - April 10th, 2021
- Real-time imaging shines light on the coordination of neural stem cell activation - News-Medical.net - April 10th, 2021
- Searching for Molecular Targets in Myeloid Malignancies and Beyond - OncLive - April 10th, 2021
- Fitore Nutrition Launches Spectrum + to Better the Lives of Children With Autism - Influencive - April 10th, 2021
- Cancer Stem Cells Market By Size Estimation, Growth Rate, Regional Analysis With with the CAGR of 11.0% Over the Forecast Period. KSU | The Sentinel... - April 10th, 2021
- global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030 - GlobeNewswire - April 10th, 2021
- Adipose Derived Stem Cell Therapy Market New Business Opportunities And Investment Research Report 2020-2027 | Coherent Market Insights KSU | The... - April 10th, 2021
- Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 - GlobeNewswire - April 10th, 2021
- New local publication and book-signing event - Bowling Green Daily News - April 6th, 2021
- Human blastocyst-like structures generated entirely from pluripotent stem cells. Shifting the paradigm of developmental biology? - ESHRE - April 3rd, 2021
- Comprehensive Report on Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Cellular Dynamics... - April 3rd, 2021
- New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV - News-Medical.Net - April 3rd, 2021
- New research offers hope to women with POI - Austin Daily Herald - Austin Herald - April 3rd, 2021
- Stem Cell Therapy Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals,... - April 3rd, 2021
- The entelechy test: embryos and simbryos - BioNews - March 30th, 2021
- Multiple sclerosis: Recent research on causes and treatments - Medical News Today - March 30th, 2021
- Global Regenerative Medicine Conference, NCRM NICHE with Fujio Cup Quiz (FCQ), E-poster and Edogawa NICH - Times of India - March 30th, 2021
- Study: Anti-Inflammatory Therapies Could Reduce Heart Disease Risk in Elderly Patients With Clonal Hematopoiesis - Pharmacy Times - March 30th, 2021
- Can This New Electrophysiology Technology Boost Neurology Research? - Labiotech.eu - March 30th, 2021
- Stem Cell Characterization and Analysis ToolMarket Size, Share, Industry Analysis, Forecast and Global Research Report to 2027 - The Market Eagle - March 30th, 2021
- Researchers describe the systems that manage embryonic stem cells - Microbioz India - March 26th, 2021
- Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire - FierceBiotech - March 26th, 2021
- Stem cells - a mix of promise and hype - ABC News - March 26th, 2021
- Global Vaccine, Insulin and Stem Cell Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026 The Bisouv Network... - March 26th, 2021
- Stem cell therapy could help restore debilitating age-related muscle loss - News-Medical.Net - March 24th, 2021
- Cell Culture: Disrupting the Meat Industry - Open Access Government - March 24th, 2021
- Canine Stem Cell Therapy Market Research and New Developments 2021-2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - March 24th, 2021
- Two In-Space Production Applications and Calls for Proposals Announced - Genetic Engineering & Biotechnology News - March 24th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2020-2027 Onset of Advanced Technologies to Upsurge the Growth The Courier - The Courier - March 24th, 2021
- Trending News: Stem Cell Cartilage Regeneration Market New Research Report 2021 to 2027| Anika Therapeutics, Zimmer Biomet, BioTissue Technologies -... - March 24th, 2021
- Stem cell therapy could help bear recover from painful disease - FOX 35 Orlando - March 20th, 2021
- The J&J vaccine was developed with stem cells. Thats caused confusion and division among Catholics. - OregonLive - March 20th, 2021
- Adipose-derived Stem Cell Overview Market Trend, Growth, Size, Forecast, Key Players and Competitive Landscape Research Report by2027 The Courier -... - March 20th, 2021
- Scientists Grow Tear Gland Organoids That Can Actually Cry - Freethink - March 20th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market Predicted to Witness Surge in the Near Future 2018 to 2028 KSU | The Sentinel Newspaper - KSU | The... - March 18th, 2021
- Catholic opinions on Johnson & Johnson vaccine highlight debate between hardliners on abortion and others in the church - Fairfield Citizen - March 18th, 2021
- Original Error: Retracing the History of the Mutation That Gave Rise to Cancer Decades Later - SciTechDaily - March 11th, 2021
- Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells - News-Medical.net - March 11th, 2021
- New multi-faculty Centre for Cell Therapy Translation gives UCalgary skin in the game for regenerative medicine research - UCalgary News - March 11th, 2021
- Policymakers urged to extend the 14-day limit on embryo research - BioNews - March 11th, 2021
- The Sacramento Business Journal announced that Cate Dyer, CEO, and founder of StemExpress, has been selected as one of SBJ's 2021 Most Admired CEOs -... - March 11th, 2021
- Coronavirus Insights: Ongoing Updates Covering The Impact On Induced Pluripotent Stem Cell Market - The Courier - March 11th, 2021
- Longeveron and University of Miami Expand Exclusive License Agreement, and Enter into CRADA To Facilitate Future Collaborations - GlobeNewswire - March 11th, 2021
- Adipose Stem Cells (ASCS) Market 2021 Global Analysis and Outlook: LifeCell, EMD Millipore, Geron, BrainStorm Cell Therapeutics, Minerva... - March 11th, 2021
- Stem cells: Therapy, controversy, and research - March 5th, 2021
- Human embryo research beyond the primitive streak - Science - March 5th, 2021
- Research Antibodies Market Size to Reach USD 5325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem... - March 5th, 2021
- Stem Cell Therapy Market Research Reveals Enhanced Growth During The Forecast Period 2017 2025 FLA News - FLA News - March 5th, 2021
- Astrocytes Derived from Patients with Bipolar Disorder Malfunction - UC San Diego Health - March 5th, 2021
- Global Stem Cell Therapy Market Booming Market To Hit $ 18.66 Billion By 2027 With Top Key Players Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd.... - March 5th, 2021
- Stem Cell Derived Exosome Production in Stirred-Tank Bioreactors - BioProcess Insider - March 5th, 2021
- Researchers study iPSCs to uncover genetic causes of disease - Drug Target Review - March 5th, 2021
- Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know - Benzinga - March 5th, 2021
- Intrapericardial injection provides a less invasive means of treating cardiac injury - News-Medical.Net - March 5th, 2021
- Individualized brain cell grafts reverse Parkinson's symptoms in monkeys - University of Wisconsin-Madison - March 3rd, 2021
- New Controversy for Stem Cell Therapy That Repairs Spinal Cords - The Great Courses Daily News - March 3rd, 2021
- Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic - BioSpace - March 3rd, 2021
- NSAIDs to Treat Arthritic Canines Through 2028; Stem Cell Therapies to Invigorate Canine Arthritis T - PharmiWeb.com - March 3rd, 2021
- A region within GLI1 gene could potentially be targeted as cancer treatment - News-Medical.Net - March 3rd, 2021
- Magenta Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Program Highlights - Galveston County Daily News - March 3rd, 2021
- Global Animal Stem Cell Therapy Market 2020 2025 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak KSU... - March 3rd, 2021
- Global Autologous stem cell and Non-stem cell based Therapies Market- Industry Analysis, Growth, Segmentation and Forecast-2019-2027 - The Bisouv... - March 3rd, 2021
- Stem Cell manufacturing Market Witness an Outstanding Growth and Strong Revenue and Forecast 2027 KSU | The Sentinel Newspaper - KSU | The Sentinel... - March 3rd, 2021
- New study launches into COVID-19 vaccine responses in patients with impaired immune systems - University of Birmingham - March 3rd, 2021
- U. Cancer Center pilot projects: investigating cancer connections - The Brown Daily Herald - March 3rd, 2021
- Animal Stem Cell Therapy Market Size 2021 | Global Trends, Business Overview, Challenges, Opportunities and Forecast to 2027 The Bisouv Network - The... - March 1st, 2021
- Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests - UC San Diego Health - March 1st, 2021
- Contemporary Critical Care Complications of Stem Cell Transplant/Cellular Therapies - TMC News - Texas Medical Center News - March 1st, 2021
- Global Human Embryonic Stem Cells Market Size-Share Analysis and System Production | Addressing the Potential Impact of COVID-19 Top Companies FLA... - February 21st, 2021
- Studies Show ApoE4 Carriers Appear More Susceptible to COVID-19Experts Say the Jury Is Still Out - Being Patient - February 21st, 2021
- Global Stem Cell Therapy Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 KSU | The Sentinel... - February 19th, 2021